Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013

Clin Infect Dis. 2015 May 1;60(9):1346-56. doi: 10.1093/cid/civ059. Epub 2015 Feb 2.

Abstract

Background: High antenatal human immunodeficiency virus (HIV) seroprevalence rates (∼ 30%) with low perinatal HIV transmission rates (2.5%), due to HIV prevention of mother-to-child transmission program improvements in South Africa, has resulted in increasing numbers of HIV-exposed but uninfected (HEU) children. We aimed to describe the epidemiology of invasive pneumococcal disease (IPD) in HEU infants.

Methods: We conducted a cross-sectional study of infants aged <1 year with IPD enrolled in a national, laboratory-based surveillance program for incidence estimations. Incidence was reported for 2 time points, 2009 and 2013. At enhanced sites we collected additional data including HIV status and in-hospital outcome.

Results: We identified 2099 IPD cases in infants from 2009 to 2013 from all sites. In infants from enhanced sites (n = 1015), 92% had known HIV exposure status and 86% had known outcomes. IPD incidence was highest in HIV-infected infants, ranging from 272 to 654 per 100,000 population between time points (2013 and 2009), followed by HEU (33-88 per 100,000) and HIV-unexposed and uninfected (HUU) infants (18-28 per 100,000). The case-fatality rate in HEU infants (29% [74/253]) was intermediate between HUU (25% [94/377]) and HIV-infected infants (34% [81/242]). When restricted to infants <6 months of age, HEU infants (37% [59/175]) were at significantly higher risk of dying than HUU infants (32% [51/228]; adjusted relative risk ratio, 1.76 [95% confidence interval, 1.09-2.85]).

Discussion: HEU infants are at increased risk of IPD and mortality from IPD compared with HUU children, especially as young infants. HEU infants, whose numbers will likely continue to increase, should be prioritized for interventions such as pneumococcal vaccination along with HIV-infected infants and children.

Keywords: HIV exposure; South Africa; Streptococcus pneumoniae; children; pneumococcal conjugate vaccine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cross-Sectional Studies
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / microbiology*
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Pneumococcal Infections / complications
  • Pneumococcal Infections / epidemiology*
  • Pneumococcal Infections / mortality*
  • Pneumococcal Infections / virology
  • Pneumococcal Vaccines / administration & dosage
  • Regression Analysis
  • Risk Factors
  • Seroepidemiologic Studies
  • South Africa / epidemiology
  • Time Factors

Substances

  • Pneumococcal Vaccines